Market Closed -
Toronto S.E.
03:47:28 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.085
CAD
|
+6.25%
|
|
-5.56%
|
-39.29%
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
58.61
|
27.87
|
19.36
|
55.89
|
40.19
|
36.27
|
Enterprise Value (EV)
1 |
63.27
|
32.53
|
26.23
|
42.02
|
36.42
|
52.93
|
P/E ratio
|
-4.71
x
|
-2.27
x
|
-1.85
x
|
-4.54
x
|
-5.2
x
|
-6.92
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1,015
x
|
11.8
x
|
2.45
x
|
5.88
x
|
1.99
x
|
1.38
x
|
EV / Revenue
|
1,095
x
|
13.8
x
|
3.32
x
|
4.42
x
|
1.81
x
|
2.01
x
|
EV / EBITDA
|
-6.27
x
|
-4.46
x
|
34.4
x
|
-8.76
x
|
-5.46
x
|
-335
x
|
EV / FCF
|
-3.79
x
|
-4.21
x
|
-7.02
x
|
-6.33
x
|
-3.73
x
|
-18.6
x
|
FCF Yield
|
-26.4%
|
-23.8%
|
-14.2%
|
-15.8%
|
-26.8%
|
-5.38%
|
Price to Book
|
1.8
x
|
0.77
x
|
0.69
x
|
1.17
x
|
0.92
x
|
0.74
x
|
Nbr of stocks (in thousands)
|
90,164
|
126,666
|
138,302
|
199,592
|
206,095
|
259,089
|
Reference price
2 |
0.6500
|
0.2200
|
0.1400
|
0.2800
|
0.1950
|
0.1400
|
Announcement Date
|
3/29/19
|
3/17/20
|
3/3/21
|
2/24/22
|
2/27/23
|
2/29/24
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.0578
|
2.361
|
7.907
|
9.499
|
20.15
|
26.34
|
EBITDA
1 |
-10.1
|
-7.298
|
0.763
|
-4.795
|
-6.666
|
-0.158
|
EBIT
1 |
-10.29
|
-8.299
|
-0.01
|
-5.501
|
-8.542
|
-1.451
|
Operating Margin
|
-17,821.52%
|
-351.5%
|
-0.13%
|
-57.91%
|
-42.39%
|
-5.51%
|
Earnings before Tax (EBT)
1 |
-12.95
|
-9.593
|
-8.545
|
-12.33
|
-6.254
|
-2.996
|
Net income
1 |
-10.53
|
-9.769
|
-10.17
|
-11.23
|
-7.542
|
-5.07
|
Net margin
|
-18,227.44%
|
-413.77%
|
-128.63%
|
-118.27%
|
-37.43%
|
-19.25%
|
EPS
2 |
-0.1379
|
-0.0971
|
-0.0756
|
-0.0617
|
-0.0375
|
-0.0202
|
Free Cash Flow
1 |
-16.68
|
-7.728
|
-3.734
|
-6.638
|
-9.752
|
-2.849
|
FCF margin
|
-28,881.23%
|
-327.32%
|
-47.23%
|
-69.88%
|
-48.4%
|
-10.81%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/29/19
|
3/17/20
|
3/3/21
|
2/24/22
|
2/27/23
|
2/29/24
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
4.66
|
4.66
|
6.87
|
-
|
-
|
16.7
|
Net Cash position
1 |
-
|
-
|
-
|
13.9
|
3.77
|
-
|
Leverage (Debt/EBITDA)
|
-0.4615
x
|
-0.6387
x
|
9.004
x
|
-
|
-
|
-105.5
x
|
Free Cash Flow
1 |
-16.7
|
-7.73
|
-3.73
|
-6.64
|
-9.75
|
-2.85
|
ROE (net income / shareholders' equity)
|
-57.6%
|
-27.8%
|
-30.1%
|
-29.2%
|
-13.8%
|
-10.6%
|
ROA (Net income/ Total Assets)
|
-28.8%
|
-12.1%
|
-0.01%
|
-7.53%
|
-9.08%
|
-1.21%
|
Assets
1 |
36.57
|
80.64
|
70,145
|
149.3
|
83.07
|
418.1
|
Book Value Per Share
2 |
0.3600
|
0.2900
|
0.2000
|
0.2400
|
0.2100
|
0.1900
|
Cash Flow per Share
2 |
0.0100
|
0.0200
|
0
|
0.0700
|
0.0300
|
0
|
Capex
1 |
13.4
|
6.93
|
0.76
|
0.59
|
1.44
|
3.56
|
Capex / Sales
|
23,120.49%
|
293.31%
|
9.62%
|
6.25%
|
7.16%
|
13.51%
|
Announcement Date
|
3/29/19
|
3/17/20
|
3/3/21
|
2/24/22
|
2/27/23
|
2/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -39.29% | 17.71M | | +31.96% | 272M | | +33.74% | 261M | | +49.42% | 194M | | +44.98% | 131M | | -28.57% | 121M | | +115.91% | 119M | | 0.00% | 86.82M | | +150.00% | 75.33M | | +1.20% | 55.24M |
Medical Farming
|